Can Next Generation Sequencing Play a Role in Detecting Pathogens in Synovial Fluid?
Overview
Orthopedics
Authors
Affiliations
Aims: The diagnosis of periprosthetic joint infection can be difficult due to the high rate of culture-negative infections. The aim of this study was to assess the use of next-generation sequencing for detecting organisms in synovial fluid.
Materials And Methods: In this prospective, single-blinded study, 86 anonymized samples of synovial fluid were obtained from patients undergoing aspiration of the hip or knee as part of the investigation of a periprosthetic infection. A panel of synovial fluid tests, including levels of C-reactive protein, human neutrophil elastase, total neutrophil count, alpha-defensin, and culture were performed prior to next-generation sequencing.
Results: Of these 86 samples, 30 were alpha-defensin-positive and culture-positive (Group I), 24 were alpha-defensin-positive and culture-negative (Group II) and 32 were alpha-defensin-negative and culture-negative (Group III). Next-generation sequencing was concordant with 25 results for Group I. In four of these, it detected antibiotic resistant bacteria whereas culture did not. In another four samples with relatively low levels of inflammatory biomarkers, culture was positive but next-generation sequencing was negative. A total of ten samples had a positive next-generation sequencing result and a negative culture. In five of these, alpha-defensin was positive and the levels of inflammatory markers were high. In the other five, alpha-defensin was negative and the levels of inflammatory markers were low. While next-generation sequencing detected several organisms in each sample, in most samples with a higher probability of infection, there was a predominant organism present, while in those presumed not to be infected, many organisms were identified with no predominant organism.
Conclusion: Pathogens causing periprosthetic infection in both culture-positive and culture-negative samples of synovial fluid could be identified by next-generation sequencing. Cite this article: 2018;100-B:127-33.
Ding H, Huang J, Lin L, Chen Y, Wang Q, Li W Front Cell Infect Microbiol. 2024; 14:1457639.
PMID: 39654973 PMC: 11625738. DOI: 10.3389/fcimb.2024.1457639.
Gioitta Iachino S, Scaggiante F, Mazzarisi C, Schaller C Antibiotics (Basel). 2024; 13(10).
PMID: 39452200 PMC: 11505334. DOI: 10.3390/antibiotics13100931.
Bonanzinga T, Conte P, Anzillotti G, Longobardi V, Kon E, Rescigno M EFORT Open Rev. 2024; 9(10):969-979.
PMID: 39360783 PMC: 11457803. DOI: 10.1530/EOR-23-0191.
Kaschner J, Theil C, Gosheger G, Schwarze J, Putzler J, Schaumburg F BMC Microbiol. 2024; 24(1):335.
PMID: 39256688 PMC: 11384794. DOI: 10.1186/s12866-024-03493-0.
Periprosthetic hip infection: Current concepts and the Wrightington experience.
Sahemey R, As-Sultany M, Wynn Jones H, Chitre A, Panchani S, Subudhi C J Clin Orthop Trauma. 2024; 55:102509.
PMID: 39184529 PMC: 11341938. DOI: 10.1016/j.jcot.2024.102509.